Influence of Kidney Performance and Magnesium on Formation of (OH)2-vitamin D3
Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT04237480
Collaborator
(none)
50,000
28.8
Study Details
Study Description
Brief Summary
Retrospective database analysis. The target values are the serum values of 25(OH)D, of 1,25(OH)2D, of magnesium and creatinine as well as age and sex of the patients. The laboratory values of the years 2017 and 2018 are included. There are no additional measurements on patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The laboratory values of the years 2017 and 2018 are included. All laboratory results to be evaluated originate from Medics Labor in Bern. We expect about 50'000 data sets. It is impossible for the study team to draw conclusions about the patients or the senders.
Study Design
Study Type:
Observational
Actual Enrollment
:
50000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Influence of Kidney Performance and Magnesium on the Biomarkers of Vitamin D
Actual Study Start Date
:
Jan 1, 2017
Actual Primary Completion Date
:
Dec 31, 2018
Actual Study Completion Date
:
May 28, 2019
Outcome Measures
Primary Outcome Measures
- correlation of serum values of 1,25(OH)2 vitamin D with estimated glomerular filtration rate [2017 - 2018]
statistical evaluation of serum values
- correlation of serum values of 1,25(OH)2 vitamin D with magnesium [2017 - 2018]
statistical evaluation of serum values
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- all data sets available
Exclusion Criteria:
- a declaration from the patient that his laboratory values may not be included in an evaluation.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital, Basel, Switzerland
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT04237480
Other Study ID Numbers:
- 2018-00923
First Posted:
Jan 23, 2020
Last Update Posted:
Feb 11, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
Additional relevant MeSH terms: